Bin Naeem Sameen, Baloch Naqib U, Jhatial Mussadique A, Abbas Mansoor, Fasih Samir, Masood Sheikh Rizwan, Hamdani Syed Abdul M, Siddiqui Neelam
Medical Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, PAK.
Cureus. 2023 May 11;15(5):e38892. doi: 10.7759/cureus.38892. eCollection 2023 May.
Background Granulosa cell tumor (GCT) is rare among all ovarian cancers. Its overall prognosis is favorable; however, the presence of extra-ovarian disease is associated with worse clinical outcomes. We report a retrospective analysis of granulosa cell tumors to evaluate the clinicopathological features and their outcomes. Methods This retrospective study included 54 adult patients aged 13 years and older. After data extraction and scrutiny, only those patients who were treated and followed up later at our institute were included in this study. Results Fifty-four patients were evaluated in this study, with a median age of 38.5 years. Most of the patients had dysfunctional uterine bleeding and abdominal pain (40.7%, n=22). The majority (n=26, 48%) underwent completion surgery as per ovarian protocol; however, 16.7% (n=09) patients underwent simple total abdominal hysterectomy with a bilateral salpingo-oophorectomy (TAH+BSO), debulking surgery in 3.7% (n=2), unilateral salpingo-oophorectomy in 20.4% (n=11) and fertility-sparing surgery in 11.1% (n=06) of the patients. Pathological stage I-A was found in 59.3%(n=32), I-C in 25.9% (n=14), II-A in 1.9% (n=1), III-A in 1.9% (n=1), III-C in 9.3% (n=5) and IV-B in 1.9% (n=1) of the population. Eleven (20.3%) patients relapsed during their course of treatment. Out of these 11 patients, three went into remission, two still have active disease, and six patients died. Conclusion Post-menopausal patients, more advanced disease at presentation, capsular rupture, presence of ascites, omental involvement, peritoneal spread, and residual disease after surgical resection were the main contributing factors towards poorer outcomes affecting disease-free survival. Overall median disease-free survival was 60 months for all the stage groups, while the overall survival was 62 months.
颗粒细胞瘤(GCT)在所有卵巢癌中较为罕见。其总体预后良好;然而,存在卵巢外疾病与较差的临床结局相关。我们报告了一项颗粒细胞瘤的回顾性分析,以评估其临床病理特征及其结局。
这项回顾性研究纳入了54名年龄在13岁及以上的成年患者。在数据提取和审查后,仅纳入那些后来在我们研究所接受治疗和随访的患者。
本研究共评估了54名患者,中位年龄为38.5岁。大多数患者有功能失调性子宫出血和腹痛(40.7%,n = 22)。大多数(n = 26,48%)患者按照卵巢手术方案接受了根治性手术;然而,16.7%(n = 9)的患者接受了单纯全腹子宫切除术加双侧输卵管卵巢切除术(TAH + BSO),3.7%(n = 2)的患者接受了肿瘤减灭术,20.4%(n = 11)的患者接受了单侧输卵管卵巢切除术,11.1%(n = 6)的患者接受了保留生育功能手术。病理分期I - A的患者占59.3%(n = 32),I - C的患者占25.9%(n = 14),II - A的患者占1.9%(n = 1),III - A的患者占1.9%(n = 1),III - C的患者占9.3%(n = 5),IV - B的患者占1.9%(n = 1)。11名(20.3%)患者在治疗过程中复发。在这11名患者中,3名进入缓解期,2名仍有活动性疾病,6名患者死亡。
绝经后患者、就诊时疾病分期较晚、包膜破裂、存在腹水、大网膜受累、腹膜播散以及手术切除后残留疾病是影响无病生存结局较差的主要因素。所有分期组的总体无病生存中位时间为60个月,总体生存时间为62个月。